A propensity for phenotype switching has been recognised in melanoma tumours, whereby cells are able to transition between proliferative’ and invasive’ states, with cells undergoing transcriptional reprogramming governed by distinct transcriptional regulators, most notably the MITF melanocytic master regulator [4–6]. This evidence concerns the gene MITF and melanoma.